Lucid Diagnostics (LUCD) Return on Sales (2021 - 2026)

Lucid Diagnostics (LUCD) has 6 years of Return on Sales data on file, last reported at 0.11% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales rose 22.0% year-over-year to 0.11%; the trailing twelve-month figure through Mar 2026 stood at 0.09% (up 6.0% YoY), and the FY2025 full-year result was 0.12%, down 2.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.11%, up from 0.11% in the prior quarter.
• Across five years, Return on Sales topped out at 0.04% in Q2 2025 and bottomed at 1.89% in Q3 2022.
• The 5-year median for Return on Sales is 0.11% (2024), against an average of 0.41%.
• The widest annual swing landed in 2022, when Return on Sales plunged 154 bps; it then jumped 171 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 1.33% in 2022, then jumped by 92 bps to 0.1% in 2023, then grew by 7 bps to 0.1% in 2024, then dropped by 12 bps to 0.11% in 2025, then increased by 1 bps to 0.11% in 2026.
• The last three Return on Sales figures came in at 0.11% (Q1 2026), 0.11% (Q4 2025), and 0.09% (Q3 2025), per Business Quant data.

Peer Comparison